Join Gokul Ramadoss on September 24 at 7:30 pm. This virtual event will focus on the
development of safer and more precise CRISPR tools for therapeutic genetic/epigenetic
editing. Dr. Ramadoss is especially interested in applying these tools to treat neurodegenerative
diseases. Gokul Ramadoss is a PhD student at the University of California San Francisco
focused on treating genetic diseases that affect the brain and spinal cord.